Medical Doctor Program year 2025 Reported 2019–2025 Source: CMS Open Payments, 2026 publication

Kelly Laurenti

Pediatric Ophthalmology and Strabismus Specialist Wheaton, IL Medical Doctor

NPI 1700129442 CMS profile 4723452

2015 N Main St, Wheaton, IL 60187

Open in the dashboard

General payments

$372

6 records reported · program years 2019–2025

Research payments

$2,649

Paid to them · 12 records reported · program years 2019–2025

Ownership & investment interest

$0

None reported

Through program year 2025, Kelly Laurenti of Wheaton, IL is reported in the CMS Open Payments database as having received $372 across 6 general payments and $2,649 in research payments paid to them.

No combined total General, research and ownership are kept apart. Each is reported under its own rules, and ownership is not money that moved at all but the value of a stake held. A meal, a clinical trial grant and a shareholding do not add up to anything meaningful, so this site does not add them.

General payments for this record sit in the 87th percentile of Pediatric Ophthalmology and Strabismus Specialist profiles with reported payments. Percentile describes the distribution, not the conduct.

By program year

6 rows
Year Kind Relative to this record's peak year Amount Records
2025 General $30 1
2023 General $274 2
2022 General $23 1
2020 General $19 1
2019 General $26 1
2019 Research $2,649 12

Beside peers

Year by year, beside peers General payments · among profiles paid that year
  • Kelly Laurenti
  • Pediatric Ophthalmology and Strabismus Specialist median
  • Middle half of Pediatric Ophthalmology and Strabismus Specialist
  • National median

In program year 2025, general payments to Kelly Laurenti were reported at $30. Among 124 Pediatric Ophthalmology and Strabismus Specialist profiles paid that year, the median was $118 and the middle half received between $36 and $253.

Show as a table
Year Kelly Laurenti Pediatric Ophthalmology and Strabismus Specialist median Middle half National median
2019 $26 $106 $24–$276 $163
2020 $19 $54 $19–$171 $114
2021 $0 $118 $25–$225 $132
2022 $23 $97 $40–$324 $149
2023 $274 $139 $78–$441 $160
2024 $0 $114 $35–$313 $164
2025 $30 $118 $36–$253 $169

Breakdown

Who paid General payments · program years 2019–2025
  1. Glaukos Corporation $188 2 payments
  2. Johnson & Johnson Surgical Vision, Inc. $109 1 payment
  3. Alcon Vision LLC $30 1 payment
  4. Sight Sciences, Inc. $26 1 payment
  5. Carl Zeiss Meditec AG $19 1 payment

Every payment, record by record

What the payments were for General payments · program years 2019–2025
  1. Food and Beverage $353 5 payments
  2. Gift $19 1 payment
Products named General payments · program years 2019–2025
  1. iAccess Precision Blade $165 1 payment
  2. iStent inject Trabecular Micro-Bypass System Model G2-M-IS $165 1 payment
  3. Tecnis Simplicity $109 1 payment
  4. VERITAS Vision System $109 1 payment
  5. Tecnis IOL Optics $109 1 payment
  6. Tecnis IOL Optics $109 1 payment
  7. TRYPTYR $30 1 payment
  8. OMNI $26 1 payment
  9. None Specified $19 1 payment

A payment can name more than one product, so these amounts overlap and do not add up to the general-payment figure.

Research payments came from Research payments · program years 2019–2025
  1. Regeneron Pharmaceuticals, Inc. $2,649 12 payments

Records

18 reported

Every payment, record by record

Date, company, amount, what it was for and the product named — filter by year, kind and company, or download as CSV.

Other Pediatric Ophthalmology and Strabismus Specialist in Illinois

Related records

What this means

U.S. law requires drug and medical device manufacturers to report payments and transfers of value they make to physicians and teaching hospitals. The Centers for Medicare & Medicaid Services publishes that record each year. This page shows what was reported about this person, and nothing else.

An ownership interest is different from the other two. It is not a payment: it is a stake — shares, options, a partnership holding — that a physician or an immediate family member held in a manufacturer during that year. The figure shown is what the stake was reported to be worth.

Research payments frequently pass through a clinician to the institution running a trial, and rarely represent personal income. They should be read differently from general payments.

Provenance

Source: CMS Open Payments · through program year 2025

Data current to program year 2025, from CMS's 2026 publication.

We reproduce what manufacturers reported. We do not verify, edit or correct the underlying records.

A payment record is not evidence of wrongdoing. Financial relationships between industry and medicine are legal, common and often necessary for research. Who Paid My Doc reports what was disclosed; it does not judge it.

Who Paid My Doc is independent and is not affiliated with, endorsed by or sponsored by CMS or any U.S. government agency. It is not a consumer reporting agency and this is not a consumer report; do not use it for decisions covered by the Fair Credit Reporting Act.

How to dispute or correct a record